Nasdaq · CIK 0001374328
FTLF FITLIFE BRANDS, INC.
Insider trading from SEC Form 4. Last filing 41 d ago. Close $9.21 on Oct 9, 2026, +6% from the 52-week low and -55% from the high.
FITLIFE BRANDS, INC. (FTLF) has 13 SEC Form 4 filings on file from 7 insiders, the latest filed on Sep 2, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
7 open-market trades have been scored at FTLF. The newest: Seth Yakatan (director) bought $2,519 of stock on Jan 15, 2026, filed Apr 20, 2026, scored 10 (weak), under a 10b5-1 plan. The largest of the 7 shown: Matthew Lingenbrink (director) bought $37k on Apr 14, 2025, scored 52 (moderate). 2 insiders bought within 14 days of each other around Apr 10, 2026.
FTLF closed at $9.21 on Oct 9, 2026, 6% above its 52-week low and 55% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at FITLIFE BRANDS, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | Seth Yakatan director buy | $2,519 164 shares | +38% | +50% from low-25% from high | |
| 46Moderate | Grant Robert Dawson director buy | $30k 3,000 shares | +2% | 0% from low-54% from high | |
| 56Moderate | Matthew Lingenbrink director buy | $29k 3,000 shares | +52% | 0% from low-54% from high | |
| 52Moderate | Matthew Lingenbrink director buy | $37k 3,000 shares | +107% | +16% from low-31% from high | |
| 12Weak | Todd Ordal director buy | $3,621 300 shares | +0% | +18% from low-30% from high | |
| 47Moderate | Matthew Lingenbrink director buy | $34k 2,800 shares | - | 0% from low-31% from high | |
| 0Weak | Todd Ordal director buy | $4,556 150 shares | +0% | - |
Transactions
Every row filed, 17 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Jakob York CHIEF FINANCIAL OFFICER | AGrant or award Stock Optionsderivative | +4,000 | $0.00 | $0 | 4,000 | 41 d ago |
| May 15, 2026 | Ryan P. Hansen President | AGrant or award Stock Optionsderivative | +28,500 | - | - | 28,500 | May 19, 2026 |
| May 15, 2026 | Ryan P. Hansen President | AGrant or award Stock Optionsderivative | +46,500 | - | - | 75,000 | May 19, 2026 |
| May 15, 2026 | Ryan P. Hansen President | AGrant or award Performance Stock Unitsderivative | +50,000 | - | - | 125,000 | May 19, 2026 |
| Jan 15, 2026 | Seth Yakatan director | POpen-market purchase Common Stock10b5-1 | +164 | $15.36 | $2,519 | 593 | Apr 20, 2026 |
| Apr 10, 2026 | Grant Robert Dawson director | POpen-market purchase Common Stock | +3,000 | $9.98 | $30k | 158,000 | Apr 14, 2026 |
| Apr 10, 2026 | Matthew Lingenbrink director | POpen-market purchase Common Stock | +3,000 | $9.76 | $29k | 8,800 | Apr 14, 2026 |
| Sep 5, 2025 | Jakob York CHIEF FINANCIAL OFFICER | AGrant or award Stock Optionsderivative | +4,000 | $0.00 | $0 | 4,000 | Sep 8, 2025 |
| Apr 15, 2025 | Todd Ordal director | POpen-market purchase Common Stock10b5-1 | +300 | $12.07 | $3,621 | 62,488 | Apr 16, 2025 |
| Apr 14, 2025 | Matthew Lingenbrink director | POpen-market purchase Common Stock | +3,000 | $12.17 | $37k | 5,800 | Apr 16, 2025 |
| Mar 31, 2025 | Judd Dayton CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +144,000 | $2.62 | $377k | 1,031,226 | Apr 2, 2025 |
| Mar 31, 2025 | Matthew Lingenbrink director | POpen-market purchase Common Stock | +2,800 | $12.17 | $34k | 2,800 | Apr 2, 2025 |
| Mar 31, 2025 | Judd Dayton CHIEF EXECUTIVE OFFICER | MOption exercise Stock Optionsderivative | -144,000 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 28, 2025 | Grant Robert Dawson director | AGrant or award Common Stock | +2,144 | $12.68 | $27k | 155,000 | Mar 28, 2025 |
| Jan 15, 2025 | Todd Ordal director | POpen-market purchase Common Stock10b5-1 | +150 | $30.37 | $4,556 | 31,094 | Jan 16, 2025 |
| Dec 30, 2024 | Judd Dayton CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +6,200 | $0.70 | $4,340 | 443,613 | Jan 2, 2025 |
| Dec 30, 2024 | Judd Dayton CHIEF EXECUTIVE OFFICER | MOption exercise Stock Optionsderivative | -6,200 | $0.00 | $0 | 215,200 | Jan 2, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Grant Robert Dawsondirector
- Judd DaytonCHIEF EXECUTIVE OFFICER
- Ryan P. HansenPresident
- Matthew Lingenbrinkdirector
- Todd Ordaldirector
- Seth Yakatandirector
- Jakob YorkCHIEF FINANCIAL OFFICER
Questions about FTLF
Answered from the filings on this page, as of the latest one.
Are insiders buying FTLF?
No. In the last 90 days no insider at FITLIFE BRANDS, INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade FTLF on the open market?
Seth Yakatan (director) bought $2,519 of FTLF on Jan 15, 2026 and filed the Form 4 on Apr 20, 2026. InsiderTell scored 10 (weak), under a 10b5-1 plan.
How many insiders file Form 4 at FITLIFE BRANDS, INC.?
7 people have filed a Form 4 at FITLIFE BRANDS, INC., among them Grant Robert Dawson (director), Judd Dayton (CHIEF EXECUTIVE OFFICER), Ryan P. Hansen (President). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.